Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $6,406,568 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 2,675,000 | $824,622 | 12.9% | $134.94 | +154.0% | Common | 91307C102 |
| ASND | ASCENDIS PHARMA | 5,218,000 | $813,277 | 12.7% | $127.83 | — | Sponsored ADR | 04351P101 |
| ARGX | ARGENX SE | 1,235,177 | $731,058 | 11.4% | $186.36 | — | Sponsored ADR | 04016X101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 2,022,222 | $669,821 | 10.5% | $138.83 | +136.7% | Common | 558868105 |
| KRYS | KRYSTAL BIOTECH INC | 2,731,000 | $492,399 | 7.7% | $89.11 | +88.8% | Common | 501147102 |
| — | BLUEPRINT MEDICINES CORP | 3,850,000 | $340,764 | 5.3% | $88.11 | — | Common | 09627Y109 |
| APLS | APELLIS PHARMACEUTICALS INC. | 12,222,222 | $267,300 | 4.2% | $47.01 | -41.2% | Common | 03753U106 |
| RNAM | AVIDITY BIOSCIENCES INC | 7,625,000 | $225,090 | 3.5% | $22.48 | +38.5% | Common | 05370A108 |
| XENE | XENON PHARMACEUTICALS INC | 5,741,666 | $192,633 | 3.0% | $19.12 | +98.6% | Common | 98420N105 |
| SLNO | SOLENO THERAPEUTICS INC | 2,525,000 | $180,411 | 2.8% | $40.48 | +20.3% | Common | 834203309 |
| KYMR | KYMERA THERAPEUTICS INC | 6,460,000 | $176,810 | 2.8% | $35.31 | +3.2% | Common | 501575104 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,674,835 | $170,708 | 2.7% | $106.36 | -1.0% | Common | 803607100 |
| FOLD | AMICUS THERAPEUTICS INC. | 20,500,000 | $167,280 | 2.6% | $10.47 | -11.6% | Common | 03152W109 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC. | 11,111,111 | $141,556 | 2.2% | $29.27 | -37.9% | Common | 04280A100 |
| VERA | VERA THERAPEUTICS INC | 5,701,900 | $136,960 | 2.1% | $37.55 | -14.4% | Common | 92337R101 |
| — | MERUS N V | 3,000,000 | $126,270 | 2.0% | $39.83 | — | Common | N5749R100 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 2,770,100 | $108,228 | 1.7% | $35.93 | +19.9% | CLASS A ORD | 61559X104 |
| — | INTRA-CELLULAR THERAPIES INC | 625,000 | $82,450 | 1.3% | $70.93 | — | Common | 46116X101 |
| ALKS | ALKERMES PLC | 2,450,000 | $80,899 | 1.3% | $28.75 | +13.4% | Common | G01767105 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 8,700,000 | $65,250 | 1.0% | $10.72 | -24.7% | Common | 09058V103 |
| OCUL | OCULAR THERAPEUTIX INC | 8,060,000 | $59,080 | 0.9% | $6.99 | +9.9% | Common | 67576A100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 4,050,000 | $58,239 | 0.9% | $14.38 | — | SPONSORED ADR | 152309100 |
| — | 89BIO INC | 6,350,000 | $46,165 | 0.7% | $7.63 | — | Common | 282559103 |
| MNKD | MANNKIND CORP | 8,750,000 | $44,013 | 0.7% | $3.56 | +57.5% | Common | 56400P706 |
| PCVX | VAXCYTE INC | 1,000,000 | $37,760 | 0.6% | $79.91 | +0.1% | Common | 92243G108 |
| — | TOURMALINE BIO INC | 2,425,000 | $36,884 | 0.6% | $23.43 | — | Common | 89157D105 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 830,000 | $30,054 | 0.5% | $49.13 | -15.3% | Common | 90400D108 |
| TSHA | TAYSHA GENE THERAPIES INC | 19,999,999 | $27,800 | 0.4% | $2.04 | -18.0% | Common | 877619106 |
| QURE | UNIQURE NV | 2,175,000 | $23,055 | 0.4% | $8.63 | +62.4% | Common | N90064101 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,645,548 | $21,555 | 0.3% | $13.91 | -55.9% | Common | 61225M102 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 9,910,642 | $15,361 | 0.2% | $6.38 | — | Sponsored ADR | 05280R100 |
| SEPN | SEPTERNA INC | 1,337,500 | $7,744 | 0.1% | $21.57 | -47.1% | Common | 81734D104 |
| WHWK | WHITEHAWK THERAPEUTICS INC | 2,849,402 | $5,072 | 0.1% | $24.27 | -89.2% | Common | 00032Q104 |